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Abbreviations and acronyms  
ABC  ATP-binding cassette transporters 
ACAT  Acyl-CoA cholesterol acyltransferase 
Apo  apolipoprotein 
BSA  bovine serum albumin 
CEC  cholesterol efflux capacity of HDL  
CETP  cholesterol ester transfer protein 
BMI  body mass index 
BODIPY boron dipyrromethene difluoride  
CV  coefficients of variability 
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DMEM Dulbecco's Modified Eagle's medium 
DPH  1,6-diphenyl-1,3,5-hexatriene 
EC  esterified cholesterol 
FC  free cholesterol 
G  grating correction factor 
HDL  high-density lipoprotein 
HPLC  high-pressure liquid chromatography 
LDL-C low-density lipoprotein cholesterol 
METS  metabolic equivalents for task 
NMR  nuclear magnetic resonance spectroscopy 
PON  paraoxonase  
r   fluorescence anisotropy 
TC  total cholesterol 
TG  triglycerides  
VOHF  Virgin Olive Oil and HDL Functionality study 
VOO  virgin olive oil 
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Abstract  
Scope Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular 
risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to 
assess which HDL parameters were CEC determinants after virgin olive oil (VOO) ingestion. 
Methods and Results Post-hoc analyses from the VOHF study, a crossover intervention with 
three types of VOO. We assessed the relationship of 3-week changes in HDL-related 
variables after intervention periods with independence of the type of VOO. After univariate 
analyses, mixed linear models were fitted with variables related with CEC and fluidity. 
Fluidity and Apolipoprotein (Apo)A-I content in HDL was directly associated, and HDL 
oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in 
triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL 
mean size, were associated to HDL fluidity.   
Conclusions HDL fluidity, ApoA-I concentration, and oxidative status are major 
determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and 
triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically 
linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL 
functionality in humans through nutritional or pharmacological interventions.  
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Determinants for HDL cholesterol efflux capacity (CEC) were assessed. Post-hoc analyses from data 
of a crossover intervention with three types of virgin olive oil (VOO), were performed to assess the 
relationship of 3-week changes in HDL-related variables after intervention periods. HDL fluidity, 
ApoA-I concentration, and oxidative status were major determinants for CEC after VOO. The impact 
on CEC of an increase in HDL-free cholesterol and HDL mean size, and a reduction in HDL-
triglycerides and small HDL particle number could be mechanistically linked through HDL fluidity. 
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Introduction 
High-density lipoprotein (HDL) cholesterol levels have been shown to be inversely related to 
cardiovascular disease [1]. However, data from multiple gene association [2] and intervention 
[3] studies lead to consider the functional quality of HDL as a more important parameter than 
the circulating quantity of HDL. The main functional property of the HDL particle, the 
reverse cholesterol transport pathway, is the capacity of HDL to remove the excess of 
cholesterol in peripheral cells and transport it to the liver cells to be metabolized. In 
particular, cholesterol efflux, the first step of the reverse cholesterol transport, from 
macrophages to HDL in atherosclerotic plaques is thought to be critical in the anti-
atherogenic effect of HDL [4]. Cholesterol efflux capacity of HDL (CEC) has been shown to 
be inversely associated with both prevalent coronary disease and incident atherosclerotic 
cardiovascular disease and it is considered a useful biomarker for cardiovascular risk [5,6]. 
Several HDL characteristics have been related to its CEC, namely composition, 
fluidity of the monolayer, oxidative status, and size [7]. Interrelationships among these 
features have also been described. First, HDL composition deeply affects its function. The 
distribution of HDL lipids between surface and core is crucial for apolipoprotein (Apo) A-I 
stability in HDL, a key protein involved in CEC [4], although ApoA-II is also able to 
efficiently remove cholesterol from macrophages in vivo [8]. From our previous data, 
changes in HDL composition also modulate HDL fluidity [9, 10], considered an intermediate 
marker of enhanced HDL functionality [11]. Low levels of phospholipids, or high levels of 
free cholesterol (FC), on the HDL surface may contribute to a less fluid HDL, and therefore 
to a less functional one [4]. Second, HDL oxidation also plays a pivotal role in HDL 
functionality. We have previously reported that oxidized HDL are less fluid, and therefore 
less able to perform cholesterol efflux from human THP-1 macrophages [11, 12]. This 
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decrease in HDL functionality could be promoted through the impairment of the ApoA-I 
binding to cholesterol transporters due to ApoA-I/HDL oxidation [13,14]. Finally, the 
relationship between HDL particle size and CEC remains controversial [15,16]. On one hand, 
in some in vitro studies small HDL particles were the most efficient mediators of CEC [15]. 
On the other hand, large HDL particles were the best promoters for CEC in human studies, 
being also related to coronary endothelial dysfunction [16].  
From our data, and those from others, consumption of virgin olive oil (VOO) 
increases not only the plasma HDL cholesterol concentration levels [17], but also the CEC, 
and HDL fluidity [10, 18, 19], due, at least in part, to a transcriptomic effect [20]. As we have 
previously reported in experimental and human studies, phenol-containing VOO, besides to 
increase HDL fluidity [10, 18], has shown to: modify HDL composition by increasing the 
HDL content of oleic acid [21] and ApoA-I and ApoA-II levels [22], increase the HDL 
antioxidant content [23], improve the HDL oxidative status [18, 20, 23], and promote a less 
atherogenic HDL subclasses profile [18, 24]. However, it still remains unknown how these 
functional enhancements are inter-related and how they all explain an improvement in HDL 
functionality. Due to this, in this study we examined the associations between CEC and 
variables related with HDL composition, fluidity, oxidative/antioxidative status, and particle 
size after VOO consumption. Our aim was to define which parameters can be the best 
predictors for CEC after a dietary intervention which enhances it.  
Methods 
Subjects  
Thirty-three hypercholesterolemic (total cholesterol >200 mg/dL) individuals (19 men and 14 
women) were recruited from newspaper and University advertisements. Volunteers were 
preselected when non-smokers, and their clinical record, physical examination, and blood 
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pressure were within a normal range. Next, complete blood count, routine biochemical 
laboratory analyses, and urinary dipstick tests were performed. Candidates were included 
when values, other than total and low-density lipoprotein cholesterol (LDL-C), were within 
the reference range. Exclusion criteria were: LDL-C ≥190 mg/dL, triglycerides ≥350 mg/dL, 
fasting blood glucose >126 mg/dL, plasma creatinine levels >1.4 mg/dL for women and >1.5 
mg/dL for men, body mass index (BMI)>35, smokers (>1 cigarrete/day), athletes with 
physical activity (>3000 Metabolic Equivalents for Task (METS).min/day), hypertension, 
multiple allergies, intestinal diseases, chronic diseases (i.e. diabetes, cardiovascular, etc.), or 
other conditions that would impair the adherence to the study. Participants provided written 
informed consent, and the local institutional ethics committee approved the protocol (CEIC-
IMAS 2009/3347/I).  
Design and study procedure 
This work was conducted in the frame of the VOHF (Virgin Olive Oil and HDL 
Functionality) Study. A crossover, double-blind, controlled trial was performed with three 
types of olive oil: 1) a natural VOO containing its phenolic compounds; 2) this natural VOO 
enriched with its own phenolic compounds, and 3) the natural VOO enriched with both VOO 
phenolic compounds plus those from thyme in a 1:1 ratio. The three VOOs did not differ in 
fat and micronutrient composition, with the exception of the phenolic content (80, 500, and 
500 ppm, respectively). Three-week intervention periods (25 mL/day VOO) were preceded 
by two-week washout periods with refined olive oil. 24-hour urine and blood samples were 
collected at fasting state at the start of the study and before and after each treatment. A 3-day 
dietary record was administered at baseline and after each intervention period. Participants 
were asked to avoid a high intake of rich antioxidant foods (i.e. vegetables, legumes, fruits, 
etc.). A nutritionist advised to participants for replacing all types of habitually consumed raw 
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fats with the olive oils catered. Plasma EDTA and serum samples were obtained by whole 
blood centrifugation and preserved at−80ºC. The clinical trial was conducted in accordance 
with the Helsinki Declaration and the Good Clinical Practice for Trials on Medical Products 
in the European Community (http://ec.europa.eu/health/ﬁles/eudralex/vol-
10/3cc1aen_en.pdf). The protocol is registered with the International Standard Randomized 
Controlled Trial register (www.controlled-trials.com: ISRCTN77500181).                                   
 The present study is a post-hoc analysis with samples of the participants in the VOHF 
study assessing, with independence of the type of olive oil consumed, the relationship of the 
3-week changes after all intervention periods among CEC, the fluidity of the HDL 
monolayer, and variables related to HDL composition, oxidative/antioxidative status, and 
size. 
Data collection 
Anthropometric variables were recorded. Blood pressure was measured with a mercury 
sphygmomanometer after at least a 10-min rest in the seated position. Physical activity, 
recorded at baseline and at the end of the study was assessed by the Minnesota Leisure Time 
Physical Activity Questionnaire which has been validated for its use in Spanish men and 
women [25]. Plasma glucose, total cholesterol (TC), and triglycerides (TG) were measured 
by standard enzymatic automated methods, plasma HDL-cholesterol by an accelerator 
selective detergent one (ABX-Horiba Diagnostics, Montpellier, France), and ApoA-I and 
ApoA-II by immunoturbidimetry, in a PENTRA-400 automated analyzer (ABX-Horiba 
Diagnostics, Montpellier, France). Low density lipoproteins (LDL) cholesterol was calculated 
by the Friedewald equation. 
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HDL isolation  
HDL was isolated from plasma by ultracentrifugation with a density gradient preparation 
method [26], using at once two solutions of different densities, 1.006 g/mL and 1.21 g/mL. 
To ensure the purity of the HDL fractions, ApoB100 and albumin levels were determined in 
the samples by automatic immunoturbidimetric methods (ABX-Horiba Diagnostics). 
HDL composition  
Fatty acids in HDL.  HDL lipids were trans-esterified and after methanolysis, 1 mL of 
saturated NaCl solution was added to stop the reaction and 0.75 mL of hexane to extract the 
fatty acid methyl esters. Samples were centrifuged at 2212 g for 10 min and the supernatant 
injected into the chromatograph. The analysis was performed by gas chromatography 
(Agilent 7890A Series) using a capillary SP-2330 column (30 m x 0.25 mm x 0.2 μm) 
(Supelco, Bellefonte, USA), coupled to a flame ionization detector.  
Lipids and proteins in HDL. TC, FC, TG, and phospholipids in HDL were quantified by 
automatic enzymatic-colorimetric methods, and ApoA-I and ApoA-II by automatic 
immunoturbidimetric methods. Determinations were performed in a Cobas-Mira Plus 
automated analyzer (Roche, Basel, Switzerland) with reagents from Spinreact (Barcelona, 
Spain). Esterified cholesterol (EC) was quantified as TC minus FC. The TG content of the 
HDL core was assessed as the ratio between TG and EC in HDL [18].   
HDL oxidative/antioxidative status 
HDL resistance to oxidation. It was determined by the conjugated dienes formation after 
copper oxidation of isolated HDL [27]. Briefly, dialyzed HDL (10 mg/dL of HDL 
cholesterol) was incubated with cupric sulphate (5 M) in phosphate buffered saline at 37ºC 
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for 4h. Absorbance at 234 nm was continuously monitored at 3 min intervals in an INFINITE 
M200 reader (Tecan Group Ltd). The length of the lag phase was defined as the time 
(minutes) to the intercept of the tangent of the absorbance curve in the propagation phase 
with baseline. Propagation rate was expressed as the slope of the tangent (change in 
absorbance/min). Maximum dienes formation was calculated by the maximum increase of the 
absorbance at 234 nm using the molar absorbance 234nm for conjugated dienes (29.5000  L 
 mol-1  cm-1). Determinations were performed in duplicate. We used an HDL pool from 
healthy volunteers as between assay control. Data from HDL resistance to oxidation were 
only available from a subsample of 25 volunteers. 
Antioxidant compounds in HDL. Carotenoids, retinol, ubiquinol, tocopherols, and phenolic 
compounds from olive oil and thyme were analyzed by high-pressure liquid chromatography 
(HPLC) [28, 29]. Compounds were identified by their retention time compared with pure 
standards or, when unavailable (lutein and β-cryptoxanthin), with compounds obtained and 
purified in the laboratory. Determinations were run in duplicate. 
Paraoxonase 1(PON1) activity assessment 
PON1-associated lactonase activity was measured in human sera using 5-thiobutyl 
butyrolactone (a synthetic lactone) as substrate as previously described [30, 31]. This activity 
is expressed as U/L (1 U = 1μmol of substrate hydrolyzed per minute). 
Nuclear magnetic resonance spectroscopy (NMR) HDL lipoprotein particle count and 
subclasses 
Serum samples were shipped to the National Heart Lung and Blood Institute, National 
Institutes of Health (NIH; Bethesda, MD, USA). Lipoprotein subclasses measurement was 
performed by NMR in a Vantera clinical spectrometer, produced by LipoScience (Raleigh, 
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NC, USA). The NMR LipoProﬁle test by LipoScience involves measurement of the 400 MHz 
proton NMR spectrum of samples and uses the characteristic signal amplitude of the lipid 
methyl group broadcasted by every lipoprotein subfraction as the basis for quantiﬁcation. 
LipoProﬁle-3 algorithm was performed to quantify the mean particle size and concentrations 
of HDL lipoproteins. Subparticle concentrations were determined for three HDL subclasses 
(large: 8.8–13 nm; medium: 8.2– 8.8 nm; and small: 7.3–8.2 nm) [32]. 
HDL monolayer fluidity 
HDL particle fluidity was determined by the steady-state anisotropy of 1,6-diphenyl-1,3,5-
hexatriene (DPH) [18]. Briefly, HDL samples were incubated with DPH 1μM (30 min) and 
stimulated with a vertically polarized light at 360 nm. Fluorescent emission intensities were 
detected at 460 nm in a Perkin-Elmer LS5OB spectrofluorometer (Perkin Elmer, Waltham, 
MA, USA), through a polarizer orientated in parallel and perpendicular to the direction of 
polarization of the emitted beam. The steady-state fluorescence anisotropy (r) was calculated 
with the Ip values, and with the grating correction factor of the monochromator (G), using the 
following formula: r = (Ivv-GIvh)/(Ivv+2GIvh). The steady-state anisotropy refers to the 
rigidity of the sample, therefore the inverse value of this parameter (1/r) is the fluidity index. 
Determinations were performed in duplicate. 
Cholesterol Efflux determination 
Murine J-774A.1 macrophages were labeled for 1 h with TopFluor-Cholesterol, a fluorescent 
cholesterol probe in which the cholesterol molecule is linked to boron dipyrromethene 
difluoride (BODIPY) moiety (Avanti Polar Lipids, USA). The labeling of cells was 
performed in Dulbecco's Modified Eagle's medium (DMEM) containing 0.125 mM of total 
cholesterol, where TopFluor-Cholesterol accounted for 20 % of total cholesterol. Labeled 
cells were incubated for 18 h with TO-901317 (3 µM; Sigma-Aldrich, USA) to upregulate 
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ATP-binding cassette (ABC) transporters, in low-glucose DMEM supplemented with bovine 
serum albumin (BSA; 0.2 %). This assay determines CEC mediated predominantly via 
ABCA1 but also via ABCG1. Cells were then incubated for 24 h with volunteers’ HDL (100 
µg/mL). The Acyl-CoA cholesterol acyltransferase (ACAT) inhibitor Sandoz 58-035 (5 µM; 
Sigma-Aldrich, USA) was present during the whole experimental procedure. All incubations 
were performed at 37ºC in a humidified incubator. Cells were solubilized with cholic acid (1 
%) and mixed on a plate shaker for 3 h at room temperature. Fluorescence intensity of media 
and cells was monitored in Microplate Reader Synergy HT (BioTekInstruments; USA) at 
λEx/Em=485/528 nm. CEC was calculated as: [media fluorescence/(media fluorescence + 
cells fluorescence)] *100. Background efflux was subtracted from values obtained in the 
presence of HDL. Data were adjusted by the HDL particle number. We used an HDL pool 
from healthy volunteers as a between assay control. All conditions were run in triplicate. 
Intra- and inter-assay coefficients of variability (CV%) of the method were 4.87% and 6.61% 
respectively.  
Statistical analyses Normality of continuous variables was evaluated by probability plots. 
Non-normally distributed variables were log transformed. Student’s T test for related 
measurements was used for change comparisons. Univariate associations were examined by 
Pearson’s correlation coefficients. Stepwise mixed linear models were fitted with variables 
significantly associated with 3-week changes in CEC or fluidity in the univariate analyses. 
When collinearity between variables exists, separate models were fitted. Models were 
adjusted by age and sex, and individual level of test subjects as random effect. Significance 
was defined at the 5% level using a two-tailed test. Analyses were carried out using SPSS 
software version 21.0 (SPSS, Inc., Chicago, IL).   
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Results 
Baseline characteristics of the subjects are shown in Table 1. Subjects under antilipidemic 
medication did not change either their dose or type of medication through the study. No 
changes in physical activity were observed from the beginning to the end of the study. No 
changes in daily energy intake or those of micro or macronutrients were observed among 
intervention periods.  Table 2 shows pre- and post-intervention values in HDL related 
variables. A significant increase at post-intervention versus pre-intervention values was 
observed in CEC (p=0.042), HDL oleic acid concentration (p=0.009), HDL ApoA-I 
concentration (p=0.014), and antioxidants in HDL: α-tocopherol (p=0.017), β-cryptoxanthin 
(p<0.001), coenzyme-Q (p=0.005), lutein (p<0.001), retinol (p=0.011), and phenolic 
compounds (p<0.001). 
Cholesterol efflux associations 
Table 3 shows the Pearson’s correlation coefficients for the association between changes in 
CEC and in HDL fluidity, and changes in variables related to HDL composition, 
oxidative/antioxidative status, and size. CEC was directly related with the fluidity of the HDL 
(p=0.004). CEC was inversely related with concentration of linoleic acid in HDL (p=0.034) 
and with that of small HDL particles (p=0.001), but directly related to the concentration in 
HDL of stearic acid (p=0.003), ApoA-I (p=0.004), ApoA-II (p=0.001), TC (p=0.008), EC 
(p=0.40), TG (p=0.021), phospholipids (p<0.001), lag time of conjugated dienes formation 
(p=0.006), concentration in HDL of β-cryptoxanthin (p=0.008), and concentration of medium 
(p=0.012) and large (p=0.041) HDL particles.  
Results of the stepwise mixed linear models are shown in Table 4. Given that 
determinations of the lag time of conjugated dienes were not available in the whole sample 
we performed Model 1 with all variables which had significance in the univariate analyses, 
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but without entering the lag time in the model. Model 2 shows the results with all variables 
that had significance in the univariate analyses. Results of these models point out an increase 
in HDL fluidity, ApoA-I, and resistance against oxidation (lag time of conjugated dienes) as 
main determinants for CEC. Model 3 shows the results without entering HDL fluidity in the 
full model. In this case, small HDL particle number appear inversely and significantly 
related, indicating that it could be a variable which reflects the effect of fluidity on CEC. 
Thus, we performed the same analyses with fluidity as the dependent variable.  
HDL fluidity associations  
Table 3 shows the Pearson’s correlation coefficients for the univariate association between 
changes in HDL fluidity and in CEC, and changes of those variables related to HDL 
composition, oxidative/antioxidative status, and size. HDL fluidity was inversely related to 
the concentration of FC (p= 0.003) in HDL, and that of small HDL particles (p<0.001). HDL 
fluidity was directly related to the concentration of EC in HDL (p=0.036), total TG content 
(p<0.001), TG in HDL core (p=0.044), HDL mean size (p< 0.001), and with the 
concentration of medium HDL particles (p=0.027).   
Results of the stepwise mixed linear model including all variables which reached 
significance in the univariate analyses showed that the content of FC and TG in HDL and the 
concentration of small and medium HDL particles appeared as main determinants of the 
fluidity of HDL monolayer. However, the strong inverse relationship between small and 
medium HDL particles number (r= -0.752, p<0.001) (see Supplemental Figure 1) promotes a 
collinearity in the model distorting the results. Due to this, two models were fitted including 
or not small or medium HDL particles in them. Results of the models are shown in Table 5. 
An increase in TG and a decrease in FC levels in HDL, together with a decrease in small 
www.mnf-journal.com Page 16 Molecular Nutrition & Food Research 
 
This article is protected by copyright. All rights reserved. 
16 
 
HDL particle number or an increase in the HDL mean size appear as main determinants of 
the fluidity of the HDL particles. 
Discussion 
In this study, we examined the association between 3-week changes in CEC and HDL fluidity 
after VOO ingestion, as well as the association of the changes in both variables with those of 
several characteristics of the HDL. Our results point out an increase in HDL fluidity and in 
the concentration of ApoA-I in HDL, and a decrease in HDL oxidative status as major 
determinants of CEC. A reduction in FC together with an increase in TG in HDL, and a 
decrease in the concentration of small HDL particle number or an increase in HDL mean size 
appeared to be the main determinants for HDL fluidity. A schema of the interrelationships is 
depicted in Figure 1.  
 The molecular determinants of CEC are still largely unknown, and multiple pathways, 
which can be modulated by HDL composition and modification, are involved [31]. 
Mechanisms accounting for CEC include passive diffusion process as well as active pathways 
mediated by ABCA1, ABCG1, and the scavenger receptor class B type I (SR-BI). The 
posttranscriptional regulation of cholesterol efflux via ABCA1 includes mechanisms that 
involve the stabilization of ABCA1 protein by ApoA-I [4, 13]. In this sense, oxidation of 
HDL and ApoA-I results in a selective inhibition of ABCA1-dependent cholesterol efﬂux 
from macrophages [13]. The ABCA-1/ApoA-I complex absorbs antioxidants (i.e lutein, 
zeaxanthin, etc.) which are LDL-protecting molecules, thus contributing to the formation of 
nascent HDL [32]. ABCA1/ApoA-I activity is fundamental for the formation of the nascent 
HDL (pre-β1 fractions), which are also efﬁcient acceptors of cell cholesterol via ABCG1 [4]. 
In agreement with our past findings, HDL oxidation decreases HDL fluidity and 
concomitantly CEC [11, 12]. Lipoprotein oxidation promotes the linkage between fatty acids 
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reducing the mobility of the chains which increases the rigidity of the lipid monolayer [33]. 
In turn, the fluidity of the HDL monolayer influences ApoA-I conformation and binding to 
HDL [34]. Thus, a close interrelationship exists between HDL oxidative status, ApoA-I, and 
HDL fluidity, the three main factors which appear related to CEC in our study. 
Changes within the HDL lipid core can also promote HDL dysfunction. The main 
constituents of the HDL lipidome are the phospholipids, followed by EC, and by TG and FC. 
They are spatially organized according to their hydrophilic properties: phospholipids and FC 
in the external hydrophilic monolayer which encloses a hydrophobic core rich in EC and TG 
[35]. An upregulation of the activity of the cholesterol ester transfer protein (CETP), like 
occurs in insulin resistance states, alters the TG/EC ratio in HDL, the index used to assess the 
quantity of TG in the core of the HDL [18]. Higher TG contents in the lipid core impair 
transfer of EC through SR-BI, hindering CEC [36]. Despite all this referred before, data from 
human in vivo studies show that to maintain a critical pool size of triglyceride-rich 
lipoproteins, that affects cholesterol from HDL, promotes the efficiency of CEC [37]. A 
positive correlation between the capacity of plasma to effect cholesterol efflux and plasma 
levels of TG has been demonstrated in several studies [37]. Thus, the controversy concerning 
the role of TG on CEC lead us to hypothesize that maintaining an equilibrium in the TG 
content of HDL versus other lipids could be the clue for the HDL functionality. From our 
data, the influence of TG and FC on CEC could be mediated through their effect on the HDL 
fluidity. We have previously described a positive association between the content of TG, 
oleic acid, and phospholipids in HDL and the fluidity of the lipoprotein, FC content of the 
HDL being negatively associated [9]. Fluidity depends on the length and saturation of the 
fatty acids present in the phospholipids of the HDL monolayer. In this sense, a decrease in 
acyl chain length and an increase in chain unsaturation, such as in the case of oleic acid, 
increase the fluidity of the lipoprotein [38, 39]. In contrast, FC complexes with phospholipids 
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form the lipid rafts which are known to harden the membrane and to decrease its ﬂuidity [39].  
An increase in TG, a well know effector for increasing lipid membranes fluidity [40], and a 
decrease in FC in HDL were major determinants for the HDL fluidity in our population.  
A huge body of data, somewhat contradictory, exists concerning HDL size and CEC. 
On the basis of the phospholipid content, small HDL more potently promote CEC [15, 41, 
42], whereas on a particle number basis, large HDL are more effective [16, 40]. In this sense, 
recent studies in peri-menopausal women and elderly adults show CEC to be directly related 
to large and medium HDL particle concentration and inversely to that of small HDL particle 
number in multivariate adjusted models [43, 44]. In agreement with these data, in our lineal 
mixed model small HDL particles were inversely related with CEC, when fluidity was not 
present in the model. When entering the fluidity of the HDL in the model, small HDL particle 
number was no longer associated with CEC, but it was, however, inversely related with HDL 
fluidity in the mixed model when HDL fluidity was the dependent variable. In a similar way 
that occurred for the lipid HDL composition, in our models the size of the HDL lipoprotein 
seem to exert their effect on CEC through changes in the HDL monolayer fluidity, with an 
improvement at larger HDL particle size. The fluidity of the HDL, as well as its CEC, is 
considered to be inversely related to the sphingomyelin content of the HDL. The 
sphingomyelin content of the HDL subpopulations remains, at present, controversial [44]. 
The complexity of sphingomyelin species, their distribution in the different HDL particles, 
and their role in HDL fluidity and CEC is considered a promising target for future studies 
[45]. 
Our study has limitations. First, cholesterol efflux was measured ex vivo, but the 
transport of the cholesterol to the liver, the second part of the reverse cholesterol transport 
was not assessed. Because our CEC assay involved the use of cell lines [30] our results may 
not reflect the real in vivo situation. However, CEC as measured by a similar method with 
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J744 cells, but using ApoB-depleted plasma as acceptor, has been shown to be inversely 
related with cardiovascular risk [6].  A determining limitation in the study is the method used 
to isolate HDL for measuring CEC. This method limits HDL density to 1.063-1.210 g/mL 
and does not accurately represent the contribution of pre-β HDL, which is found in the 
density range 1.210–1.250 g/mL [48]. We have measured ApoA-I concentration as a 
surrogated marker for ApoA-I functionality in our study. Also, we have related 3-week 
changes in HDL variables with independence of the olive oil intervention period, the possible 
confounding effect avoided by the introduction of the individual level of test subjects as 
random effect in the model. Although this approach has advantages in mitigating the effect 
from confounding factors, it could buffer the pre-post differences. Also, the fact that our 
population was hypercholesterolemic subjects, can limit the extrapolation of the results to a 
more general population. A major strength of this study was its crossover, double-blind, 
placebo controlled design, which helps to limit the effect from confounding factors such as 
differences in physical activity or diets in tests subjects. As essential strength of our work, it 
is one of the first comprehensive association studies between HDL functional characteristics 
(also covering an intensive lipidomic and metabolomic profile) and the most relevant HDL 
functionality trait, CEC. 
Among factors which can modify CEC and HDL characteristics, besides VOO alone, 
we have reported that diets rich in VOO and antioxidants such as the Mediterranean diet have 
shown to increase the CEC together with improvements in HDL oxidative status, 
composition, ApoA-I, and HDL particle size [47–49]. Also, novel pharmaceutical approaches 
are being developed for improving HDL characteristics and functionality. Therapies based on 
the infusion of ApoA-I formulations (rHDL) in humans, increased ApoA-I levels and 
cholesterol esterification, and caused a transient accumulation of very small HDL species, 
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followed by an enlargement of particles present within medium and large HDL. These 
changes were concomitant with an increase in the CEC [50].  
In summary, by using a model as VOO consumption in which improvements in HDL 
characteristics and functionality have been reported [10, 17–24], we looked for the major 
determinants of the CEC. From our results, an increase in the fluidity of the HDL and in the 
concentration of ApoA-I in HDL, and a decrease in HDL oxidative status appear as major 
determinants of CEC. The impact of a reduction in FC, together with an increase in TG in 
HDL on CEC could be mediated by their effect increasing the fluidity of the HDL monolayer. 
The same occurs for the decrease in small HDL particle number or the increase in the HDL 
mean size. Our work point out several promising new therapeutic targets, besides HDL 
cholesterol levels, for improving HDL functionality in humans through dietary, nutraceutical, 
or pharmaceutical interventions.   
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Figure 1. A proposal model for the interrelationship among the main determinants 
(dense arrows) of HDL cholesterol efflux capacity in hypercholesterolemic subjects 
after virgin olive oil ingestion. Intermittent arrows point out the expected contribution 
of the main virgin olive oil components.  
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Table 1. Baseline characteristics of the participants 
Variable Mean ±SD 
Age, years 55.6 ± 10.0 
Gender, male/female  19/14 
Body mass index, kg/m 26.6 ± 4.5 
Physical activity, METs.min/w
*
 2423 (897-4544) 
Systolic blood pressure, mmHg 128.2 ± 14.6 
Diastolic blood pressure, mmHg 73.15 ± 10.0 
Glucose, pl,  mg/dL 90.8 ± 11.6 
Cholesterol ,pl, mg/dL  
     Total 226.4 ± 35.2 
     LDL 148.3 ± 28.8 
     HDL 53.01 ± 11.13 
Triglycerides, pl, mg/dL
 *
 114.2 (85.5 ± 145.0) 
Use of antilipemic medication, yes/no 14/19 
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Table 2. Pre- and post-intervention values in HDL related variables 
Variable Pre-intervention Post-intervention 
HDL mediated cholesterol efflux, % 3.93 ± 1.16  4.13 ± 1.40* 
Fluidity of the HDL monolayer, 1/AU 4.96 ± 0.48 5.00 ± 0.34 
HDL composition   
    Fatty acids in HDL, %   
        Arachidonic 10.32 ± 5.13 10.61 ± 7.06 
        Eicosatreanoic  0.77 ± 1.56 0.61 ± 1.15 
        Linoleic 29.40 ± 9.55 27.78 ± 15.36 
        Oleic 19.61±7.26 20.78 ± 7.15
†
 
        Palmitic  22.33 ±14.13 23.61 ± 7.27 
        Stearic 10.93 ±10.04 11.55 ± 6.85 
   Proteins in HDL, g/L   
       Apolipoprotein A-I 0.63  ± 0.16 0.66  ± 0.17
†
 
       Apolipoprotein A-II           0.17 ± 0.05 0.17 ± 0.04 
   Lipids in HDL, mg/dL   
       Total Cholesterol 31.84 ± 11.60 31.82 ± 12.05 
       Free Cholesterol 13.42 ± 6.25 12.73 ± 5.86 
       Esterified cholesterol 18.41 ± 8.05        18.45 ± 8.07 
       Triglycerides 7.22 ± 2.09 7.28 ± 2.24 
       Phospholipids 61.13 ± 18.44 60.66 ± 17.71 
Oxidative status of HDL
b
   
       Lag time, min
a
 34.09 (26.60-52.78) 35.38 (26.94-46.07) 
       Maximum absorbance, Abs 0.48 ± 0.10 0.47 ± 0.14 
       Oxidation rate, Abs/s 7.96 ± 2.52 8.14 ± 2.52 
Antioxidative status of HDL, µmols/L   
       Total phenolic content
a
 
c
 14.41 (0-144.5) 63.78 (0-585.3)
‡
 
       α-tocopherol 12.64 ± 0.70 12.77 ± 0.79* 
       γ-tocopherol 0.13 ± 0.35 0.15 ± 0.44 
       β-carotenea 1.27 (0-3.18) 1.79 (0-3.45) 
       β -cryptoxanthin 7.95 ± 2.96 8.73 ± 3.44‡ 
       Coenzime-Q 299.2 ± 192.2 324.2 ± 191.1
†
 
       Luteine 2.26 ± 1.93 2.58 ± 2.02 
       Retinol 3.39 ± 1.67 3.71 ± 2.01 
       PON1 activity, U/L
d
 5.18 ± 1.58 5.31± 1.74 
HDL particle size, µmol/L   
       HDL mean size (total)
e
  9.24 ± 0.46 9.27 ± 0.45 
       Small HDL particles 17.71 ± 6.03 16.93 ± 5.32 
       Medium HDL particles 10.80 ± 6.09 9.35 ± 4.96 
       Large HDL particles 7.07  ± 3.68         7.09 ± 3.53 
Values expressed as mean and standard deviation. AU, arbitrary units
 a
 Values expressed as 
median (25th-75th percentile) 
b
Conjugated dienes formation curve. 
c
Expressed in nmol/L. 
d
PON1, Paraoxonase-1. 
e
Expressed in nanometers. 
*
P<0.05; 
†
P<0.01;
 ‡
P<0.001  
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Table 3. Correlation coefficients (R) between 3-week changes in HDL cholesterol efflux and fluidity of the HDL 
monolayer and HDL characteristics after olive oil ingestion 
 Cholesterol     efflux Fluidity 
Variable (3-week changes)        R   P value           R P value 
 
Cholesterol efflux, % 
 
Fluidity, 1/anisotropy (AU) 
 
1 
 
0.308 
 
1 
 
0.004 
 
0.308 
 
1 
 
0.004 
 
1 
     
HDL Composition     
   Fatty acids in HDL, %     
          Arachidonic 0.043 0.700 0.097 0.387 
          Eicosatreanoic 0.084 0.456 0.033 0.768 
          Linoleic -0.235 0.034 0.057 0.613 
          Oleic 0.025 0.823 0.004 0.972 
          Palmitic 0.128 0.256 -0.155 0.156 
          Stearic 0.328 0.003 0.140 0.213 
    Proteins in HDL, g/L     
          Apolipoprotein A-I 0.309 0.004 0.123 0.264 
          Apolipoprotein A-II 0.364 0.001 0.070 0.537 
   Lipids in HDL, mg/dL     
          Total Cholesterol 0.287 0.008 -0.010 0.927 
          Free Cholesterol 0.073 0.509 -0.322 0.003 
          Esterified Cholesterol 0.225 0.040 0.229 0.036 
          Triglycerides 0.251 0.021 0.383 <0.001 
          Phospholipids 0.382 <0.001 0.186 0.091 
          Triglycerides in HDL core
* 
-0.041 0.713 0.220 0.044 
  
Oxidative/Antioxidative status of HDL 
    
  Oxidative status
†
     
          Lag time, min 0.331 0.006 -0.049 0.606 
          Maxim absorbance, Abs 0.053 0.708 0.125 0.375 
          Oxidation rate, Abs/s -0.168 0.189 0.175 0.215 
Antioxidative status of HDL, µmol/L     
          α-tocopherol, -0.021 0.859 -0.001 0.903 
          γ-tocopherol -0.022 0.850 0.069 0.549 
          β-carotene 0.044 0.701 0.016 0.892 
          β-cryptoxanthin 0.306 0.008 0.034 0.772 
          Coenzime-Q 0.128 0.291 0.075 0.539 
          Luteine 0.211 0.066 0.065 0.575 
          Retinol 0.158 0.170 -0.179 0.120 
          Phenolic compounds
‡
 0.138 0.182 0.127 0.271 
          PON1 activity, U/L 0.139 0.210 0.108 0.332 
HDL particle size, µmol/L     
          HDL mean size (total)
 ¥
 0.076 0.494 0.379 <0.001 
          Small HDL particles -0.349 0.001 -0.635 <0.001 
          Medium HDL particles 0.273 0.012 0.241 0.027 
          Large HDL particles 0.224 0.041 0.155 0.158 
 
AU, arbitrary units. PON1, Paraoxonase-1. *Calculated as triglycerides/esterified cholesterol ratio. †Conjugated 
dienes formation curve. 
‡
 nmol/L. 
¥
nanometers 
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Table 4. Determinants of 3-week changes in cholesterol efflux in hypercholesterolemic 
subjects after virgin olive oil ingestion.  
Predictor variable   
(3-week changes) 
Β coefficient SE T P value 
 
Model 1
*
 
    
  Fluidity of the HDL monolayer 0.731 0.279 2.62 0.010 
  Apolipoprotein A1 2.54 0.73 3.45 0.001 
Model 2
†
     
  Fluidity of the HDL monolayer 0.777 0.289 2.69 0.009 
     Apolipoprotein A1 2.47 0.892 2.77 0.007 
Lag time 0.008 0.004 2.36 0.022 
Model 3
‡
     
Apolipoprotein A1 1.92 0.94 2.04 0.046 
Lag time of conjugated dienes 0.008 0.004 2.26 0.027 
  Small HDL particle number -0.042 0.016 -2.68 0.009 
 
Stepwise mixed linear models adjusted for age and sex, and individual level of test subjects 
as a random effect. SE, standard error. 
*
Model 1. Without the lag time of conjugated dienes 
formation; 
†
 Model 2, including all variables; 
‡
Model 3, without fluidity of the HDL 
monolayer 
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Table 5. Determinants of 3-week changes in the HDL fluidity in hypercholesterolemic subjects 
after virgin olive oil ingestion.  
Predictor variable  
(3-week changes) 
Β coefficient SE T P value 
   
Model 1
*
 
      Free cholesterol in HDL 
 
-0.032 
 
0.007 
 
-4.73 
 
<0.001 
   Triglycerides in HDL 0.035 0.013 2.68 0.010 
   Small HDL particles -0.025 0.004 -6.28 <0.001 
Model 2
† 
    
Free cholesterol in HDL 
 
-0.035 
 
0.077 
 
-4.47 
 
<0.001 
  Triglycerides in HDL 0.061 0.014 4.25 <0.001 
   HDL mean size 0.290 0.104 2.79 0.007 
Stepwise mixed linear model adjusted for age and sex, and individual level of test subjects as 
a random effect. SE, standard error. 
*
Model 1, without medium HDL particles.
 †
Model 2, 
without small HDL particles. 
